A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Hicuity Health Partner Expands Its Relationship with Sarah Bush Lincoln Health Center

New Service Relationship Builds on Existing Tele-ICU Partnership

Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, is expanding its relationship with Sarah Bush Lincoln with the implementation of inpatient telemetry services. Sarah Bush Lincoln has partnered with Hicuity Health for tele-ICU services since 2015. The success of this ongoing critical care collaboration influenced the decision to extend the partnership to include the new telemetry services.

Hicuity Health’s Remote Cardiac Telemetry monitoring provides hospitals with 24/7 monitoring by trained and certified telemetry technicians located in dedicated technology-enabled care centers. Hicuity’s nurse-managed technicians monitor cardiac at-risk patients throughout the hospital, identifying cardiac abnormalities, and then urgently reporting them to the bedside team. Partnering with Hicuity Health’s remote monitoring service engages trained monitoring of patient waveforms and allows bedside nurses to maintain their focus on patient care rather than focusing on computer monitors and responding to false alarms.

“As a tele-ICU partner, we have been impressed by Hicuity Health’s support and collaborative approach. The expansion of our relationship to include telemetry services is a direct result of our years of experience with Hicuity. Simply put, we wanted to ensure that we were working with a team that would be an expert partner to our clinical team,” Sandra Miller, SBL VP Patient Care Continuum, CNO, said. “The decision to expand the relationship to include remote telemetry services is a strategic decision from both an operational and clinical perspective.”

“We are pleased to extend our long-term relationship with Sarah Bush Lincoln to include telemetry services,” said Lou Silverman, Chief Executive Officer of Hicuity Health. “Its addition of Hicuity Health’s Remote Cardiac Telemetry services emphasizes the hospital’s commitment to providing its staff with the support needed to ensure high quality patient care.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy